𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vivo imaging of brain lesions with [11C]CLINME, a new PET radioligand of peripheral benzodiazepine receptors

✍ Scribed by Hervé Boutin; Fabien Chauveau; Cyrille Thominiaux; Bertrand Kuhnast; Marie-Claude Grégoire; Sébastien Jan; Régine Trebossen; Frédéric Dollé; Bertrand Tavitian; Filomena Mattner; Andrew Katsifis

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
432 KB
Volume
55
Category
Article
ISSN
0894-1491

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The peripheral benzodiazepine receptor (PBR) is expressed by microglial cells in many neuropathologies involving neuroinflammation. PK11195, the reference compound for PBR, is used for positron emission tomography (PET) imaging but has a limited capacity to quantify PBR expression. Here we describe the new PBR ligand CLINME as an alternative to PK11195. In vitro and in vivo imaging properties of [^11^C]CLINME were studied in a rat model of local acute neuroinflammation, and compared with the reference compound [^11^C]PK11195, using autoradiography and PET imaging. Immunohistochemistry study was performed to validate the imaging data. [^11^C]CLINME exhibited a higher contrast between the PBR‐expressing lesion site and the intact side of the same rat brain than [^11^C]PK11195 (2.14 ± 0.09 vs. 1.62 ± 0.05 fold increase, respectively). The difference was due to a lower uptake for [^11^C]CLINME than for [^11^C]PK11195 in the non‐inflammatory part of the brain in which PBR was not expressed, while uptake levels in the lesion were similar for both tracers. Tracer localization correlated well with that of activated microglial cells, demonstrated by immunohistochemistry and PBR expression detected by autoradiography. Modeling using the simplified tissue reference model showed that R~1~ was similar for both ligands (R~1~ ∼ 1), with [^11^C]CLINME exhibiting a higher binding potential than [^11^C]PK11195 (1.07 ± 0.30 vs. 0.66 ± 0.15). The results show that [^11^C]CLINME performs better than [^11^C]PK11195 in this model. Further studies of this new compound should be carried out to better define its capacity to overcome the limitations of [^11^C]PK11195 for PBR PET imaging. © 2007 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Radiosynthesis of 2-[6-chloro-2-(4-iodop
Radiosynthesis of 2-[6-chloro-2-(4-iodophenyl)imidazo[1,2-a]pyridin-3-yl]-N-ethyl-N-[11C]methyl-acetamide, [11C]CLINME, a novel radioligand for imaging the peripheral benzodiazepine receptors with PET
✍ C. Thominiaux; F. Mattner; I. Greguric; H. Boutin; F. Chauveau; B. Kuhnast; M.-C 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 145 KB

## Abstract Recently, a new 2‐(iodophenyl)imidazo[1,2‐__a__]pyridineacetamide series has been developed as iodine‐123‐labelled radioligands for imaging the peripheral benzodiazepine receptors using single photon emission tomography. Within this series, 2‐[6‐chloro‐2‐(4‐iodophenyl)‐imidazo[1,2‐__a__

Efficient synthesis of [11C]befloxatone,
Efficient synthesis of [11C]befloxatone, a selective radioligand for the in vivo imaging of MAO-A density using PET
✍ F. Dollé; Y. Bramoullé; F. Hinnen; S. Demphel; P. George; M. Bottlaender 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 110 KB

## Abstract Carbon‐11 labelled befloxatone ((5R)‐5‐(methoxymethyl)‐3‐[4‐[(3R)‐4,4,4‐trifluoro‐3‐hydroxybutoxy]phenyl]‐2‐oxazolidinone) is a reversible and selective monoamine oxidase‐A (MAO‐A) inhibitor and appears to be a new potent PET tracer for the __in vivo__ imaging of MAO‐A density. In this

Radiosynthesis of 7-chloro-N,N-dimethyl-
Radiosynthesis of 7-chloro-N,N-dimethyl-5-[11C]methyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide, [11C]SSR180575, a novel radioligand for imaging the TSPO (peripheral benzodiazepine receptor) with PET
✍ Cyrille Thominiaux; Annelaure Damont; Bertrand Kuhnast; Stéphane Demphel; Stépha 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 168 KB

## Abstract SSR180575 (7‐chloro‐__N__,__N,__5‐trimethyl‐4‐oxo‐3‐phenyl‐3,5‐dihydro‐4__H__‐pyridazino[4,5‐__b__]indole‐1‐acetamide) is the lead compound of an original pyridazinoindole series of potent and highly selective TSPO (peripheral benzodiazepine receptor) ligands. Isotopic labeling of SSR18

Synthesis of [N-methyl-11C]-3-[(6-dimeth
Synthesis of [N-methyl-11C]-3-[(6-dimethylamino)pyridin-3-yl]-2,5-dimethyl-N, N-dipropylpyrazolo[1,5-a]pyrimidine-7-amine: A potential PET ligand for in vivo imaging of CRF1 receptors
✍ J.S. Dileep Kumar; Vattoly J. Majo; Jaya Prabhakaran; Norman R. Simpson; Ronald 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 138 KB

## Abstract A convenient synthesis of [N‐methyl‐^11^C]‐3‐[(6‐dimethylamino)pyridin‐3‐yl]‐2,5‐dimethyl‐__N__,__N__‐dipropylpyrazolo[1,5‐a]pyrimidine‐7‐amine (R121920), a highly selective CRF~1~ antagonist has been developed as a potential PET ligand. 3 ‐ [(6 ‐ methylamino)pyridin ‐ 3 ‐ yl]‐2,5‐dimet